Title:
Coronavirus vaccine: AIIMS Delhi to submit proposal for phase 3 trial of India-made Covaxin
Author:
Meghna Sen
Published:
Mint, 31 October 2020
From the article:
The All India Institute of Medical Sciences (AIIMS) in New Delhi is likely to submit a proposal to the Institute of Ethics Committee to start Phase 3 clinical trials of Bharat Biotech's Covid-19 vaccine candidate Covaxin by early next week.